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ABSTRACT 
 
Purslane is an annual succulent in the family Portulacaceae. The aim of this study was to overview therapeutic 
effects of Purslane . This review article was carried out by searching studies in PubMed, Medline, Web of Science, 
and IranMedex databases .The initial search strategy identified about 96 references. In this study,63  studies was 
accepted for further screening and met all our inclusion criteria [in English, full text, therapeutic effects of Purslane 
and dated mainly from the year 1993 to 2016.The search terms were “Purslane”, “therapeutic properties”, 
“pharmacological effects”. Purslane possesses the relaxant properties, Antioxidant effect, Anti-inflammatory effect, 
antitumor effect, Cytoprotective effect, Homogenizing effect, Anti-fungal effect, Neuroprotective Effect, Antibacterial 
Activity, Hepatoprotective effects, Bronchodilatory effect. Purslane was shown to be very useful for its 
pharmacological activity besides, medicinal properties of its extract require more clinical trial studies about the 
other practical and hidden activities of this plant. 
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INTRODUCTION 
 
The use of medicinal herbs and herbal medicines is an age-old tradition [1-21] and the recent progress in modern 
therapeutics has stimulated the use of natural product worldwide for diverse ailments and diseases [17, 20, 26-34]. 
Purslane or popularly called Purslane is an annual succulent in the family Portulacaceae extending from North 
Africa and Southern Europe through the Middle East and the Indian Subcontinent to Malaysia and Australasia[35]. 
It is a warm-climate, herbaceous succulent annual plant. It is eaten extensively as a potherb and added in soups and 
salads around the Mediterranean and tropical Asian countries and has been used as a folk medicine in many 
countries [36]. Diverse compounds have been isolated from Portulaca oleracea, such as flavonoids, alkaloids, 
polysaccharides [37], fatty acids, terpenoids, sterols, proteins vitamins and minerals [35]. Purslane possesses a wide 
spectrum of pharmacological properties such as neuroprotective [38], hepatoprotective [39], antidiabetic [40], 
antioxidant [41], antifatigue [42], anti-inflammatory [43], and anticancer activities [41, 44]. Its leaves are used for 
diarrhea, postpartum bleeding [45], and intestinal bleeding [46].  
 
Healing properties 
The relaxant properties  
The juice and aqueous extracts from the plant Purslane was tested for muscle relaxant properties on isolated nerve-
muscle preparations. Ethanolic extracts caused an initial augmentation of twitch height in chick biventer cervicis 
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preparations and then blockade which appeared to be mediated by an action directly on muscle fibres rather than on 
neuromuscular transmission. It was concluded that the neuromuscular activity of extracts of Purslane is caused by 
high concentrations of potassium ions [47]. 
 
An aqueous extract of Purslane leaves and stems produced a dose-dependent relaxation of guinea pig fundus, taenia 
coli and rabbit jejunum and a dose-dependent contraction of the rabbit aorta. The extract may, therefore, act in part 
on postsynaptic alpha-adrenoceptors and by interference with transmembrane calcium influx [48]. 
 
Antioxidant effect 
Antioxidant activities of three phenolic alkaloids, i.e., oleracein A [OA], oleracein B [OB] and oleracein E [OE], 
isolated from Purslane were determined. It was demonstrated that phenolic alkaloids served as a new class of 
antioxidant agents in this plant [49]. 
 
The protective effect of betacyanins from Purslane against the D-galactose [D-gal]-induced neurotoxicity in mice 
was assessed. These results suggest that the neuroprotective effect of betacyanins against D-gal-induced 
neurotoxicity might be caused, at least in part, by an increase in the activities of antioxidant enzymes with a 
reduction in lipid peroxidation [50]. 
 
The protective effects of ethanolic and aqueous extracts of Purslane on human lymphocyte DNA lesions were 
evaluated. These data suggest that the aqueous extract of P. oleracea can prevent oxidative DNA damage to human 
lymphocytes, which is likely due to antioxidant constituents in the extract [51]. 
 
Anti-inflammatory effect 
In an animal study, the anti-inflammatory of Purslane was examined.The result showed that Oleracone as a novel 
alkaloid showed significant anti-inflammatory effect, with quick distribution and high bioavailability [52]. 
 
Vascular inflammatory process of an aqueous extract of Purslane was investigated. AP prevents the vascular 
inflammatory process through the inhibition of intracellular ROS production and NF-κB activation as well as the 
reduction of adhesion molecule expression in TNF-α-induced HUVEC. These results suggested that AP might have 
a potential therapeutic effect by inhibiting the vascular inflammation process in vascular diseases such as 
atherosclerosis [53]. 
 
The protective effect of the aqueous extract of Purslane [AP] on diabetic vascular complications was investigated. It 
was found that the insulin immunoreactivity of the pancreatic islets remarkably increased in AP treated db/db mice 
compared with untreated db/db mice. Taken together, AP suppresses hyperglycemia and diabetic vascular 
inflammation, and prevents the development of diabetic endothelial dysfunction for the development of diabetes and 
its vascular complications [54]. 
 
Antitumor effect 
the anti-tumor effects in vivo of unique polysaccharide component [POP] from Purslane was analyzed and it was 
found that POP could significantly inhibit the growth of transplantable sarcoma 180 and potentiate the animal's 
immune responses including an increase in the number of white blood cell [WBC] and CD4 [+] T-lymphocytes, as 
well as the ratio of CD4 [+]/CD8 [+].It is suggested that the anti-tumor effect elicited by POP could be associated 
with its immunostimulating properties [55]. 
 
Cis and trans-isomers of feruloyl amides were evaluated for their antitumor activity. Long-term stability tests did not 
show any significant changes. Among all compounds and conversion mixtures collected, compound 6 exhibited the 
strongest inhibition of IL-6-induced STAT3 activation in Hep3B cells, with an IC50 value of 0.2 µM. This study is 
the first verification of the conversion rates and an equilibrium ratio of feruloyl amides. These results indicate that 
this natural material might provide useful information for the treatment of various diseases involving IL-6 and 
STAT3 [43].  
 
Cytoprotective effect  
The cytoprotective effect of ethanolic and aqueous extracts of N.sativa and P.oleracea against hemolytic damages 
induced by free radical initiator, AAPH [2, 2' azobis [2- amidinopropane] hydrochloride] was evaluated. 
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Cytoprotective effect of aqueous and ethanolic extracts of N. sativa and P. oleracea against AAPH- induced 
hemolysis may be related to antioxidant properties of these plants [56]. 
 
Homogenizing effect 
Toxicological bioassays rely upon the differences in mean-based statistical tests between the exposed and unexposed 
plants, and exceptional plant individuals are treated as statistical outliers. Recently, low toxicant concentrations have 
been observed to affect gene regulation in exposed plant stands .it was concluded that the results supported the 
hypothesis that very low toxicant concentrations may have ecological effects on fast-growing plant species [57]. 
 
Anti-fungal effect 
Root extracts of Purslane showed to inhibit zoospore motility. Inhibited zoospores rapidly settled to the bottom of 
the Petri dishes where they initially encysted, and then germinated within 1-2 h. This is the first report of factors 
which inhibit zoospore motility without killing or bursting the zoospores [58]. 
 
Neuroprotective Effect 
Potential beneficial effects of Purslane ethanolic extract [POEE] against the neurotoxicity induced by MeHg in 
cerebellum and cortex of rats was assessed. POEE pretreatment offered protection from these behavioral changes. 
MeHg intoxication also caused histopathological changes in cerebellum and cortex, which was found to be 
normalized by treatment with POEE. The present results indicate that POEE has protective effect against MeHg-
induced neurotoxicity [59].  
 
Antibacterial Activity 
Antibacterial active constituents from P. oleracea was investigated .The antibacterial activities against common 
enteropathogenic bacteria were evaluated for all compounds and the new compounds 1-4 showed significant 
antibacterial effect on enteropathogenic bacteria in vitro, which might contribute to revealing the treatment of P. 
oleracea in cases of bacillary dysentery[60].  
 
Hepatoprotective effects 
The protective effect of ethanol extract of purslane against carbon tetrachloride [CCl4]-induced hepatic toxicity in 
rats was investigated.These results demonstrate that purslane exerts protective effects against CCl4-induced damage 
in rat liver and supports a potential therapeutic use of purslane as an alternative for patients with liver diseases[61]. 
The hepatoprotective activity of the aqueous extract of the aerial parts of Purslane [P. oleracea] in combination with 
lycopene against carbon tetrachloride induced hepatotoxicity in rats was investigated.The oral administration of P. 
oleracea in combination with lycopene significantly ameliorates CCl[4] hepatotoxicity in rats[62]. 
 
Bronchodilatory effect  
The bronchodilatory effect of the boiled extract of Purslane in the airway of asthmatic patients was examined. 
Results showed that the boiled extract of Purslane caused significant increases in all measured pulmonary function 
tests [PFTs], [P < 0.05 to P < 0.01]. The onset of brochodilatory effect of extract was similar to that of theophylline 
beginning 60 min, but the effect of extract decline after 120 min after administration. In conclusion, the results of 
the present study showed that Purslane has a relatively potent but transient bronchodilatory effect on asthmatic 
airways [63]. 
CONCLUSION 
 
Purslane was shown to be very useful for its pharmacological activity besides, medicinal properties of its extract 
require more clinical trial studies about the other practical and hidden activities of this plant. 
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